• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Jobs
  • Events

Femtech Investment Round-up (October 2022)

By Femtech Insider Investment Round-ups, News November 1, 2022
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Acquisition, Biotech, Hormonal Health, News, Pharma November 11, 2021
Organon Announces Plans to Acquire Forendo Pharma, a Biotech Company Targeting Endometriosis and PCOS
Consumer Goods, Motherhood, News September 1, 2021
Belabumbum and Joyja Launch a New Line of Sustainable Leak-Proof Underwear and Ultra-Absorbent Nursing Pads
Recent Posts
  • WHOOP Integrates Medical Records Into Its App Through HealthEx Partnership
  • Oli Secures $2M From Australian Government to Establish Manufacturing for Maternal Monitoring Device
  • Canadian Women’s Health Platform June Health Raises C$2.4M with Strategic Investment From Securian Canada
  • Ultrahuman Launches M2 Live Glucose Monitoring Platform with Abbott’s Lingo CGM
  • From Snapshots to Continuous: The Race to Monitor Hormones in Real Time

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.